systematic_review
2018
High Quality
L-ornithine L-aspartate for people with cirrhosis and hepatic encephalopathy
Goh ET, Stokes CS, Sidhu SS
Published in Cochrane Database of Systematic Reviews
Key Findings
L-ornithine L-aspartate may benefit hepatic encephalopathy and mortality, but the evidence is very low certainty and dominated by small, biased trials.
Conclusions
Uncertain benefit even in the best-studied clinical indication.
Limitations
High risk of bias, small trials.
Supplements Studied
L-Ornithine
Amino Acid
L-ornithine L-aspartate may benefit hepatic encephalopathy, but the evidence is of very low certainty.
Study Details
Year:2018
Sample Size:2,137
Quality Score:9/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.